Organization
Santhera Pharmaceuticals
6 clinical trials
Clinical trial
A Phase II Open-Label, Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)Status: Active (not recruiting), Estimated PCD: 2024-07-01
Clinical trial
A Phase III Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia PatientsStatus: Completed, Estimated PCD: 2009-04-01
Clinical trial
An Open-Label, Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy Who Have Completed the Long-Term Extension (VBP15-LTE) or VBP15-004 or VBP15-006 StudiesStatus:
Clinical trial
Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS StudyStatus:
Clinical trial
Expanded Access Protocol (EAP) of Idebenone in Patients With Duchenne Muscular DystrophyStatus:
Clinical trial
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)Status: Completed, Estimated PCD: 2021-03-29